Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details)

v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
1 Months Ended
Feb. 28, 2018
Mar. 31, 2024
Dec. 31, 2023
Contingency      
Accrued research and development   $ 2,763,110 $ 2,263,934
ACX362E      
Contingency      
Future commitment $ 700,000    
Royalty payments $ 50,000    
Accrued research and development   $ 150,000 $ 150,000
Royalty payments on net sales (as a percent) 4.00%